0001607062-16-000684.txt : 20160216
0001607062-16-000684.hdr.sgml : 20160215
20160216170352
ACCESSION NUMBER: 0001607062-16-000684
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160216
FILED AS OF DATE: 20160216
DATE AS OF CHANGE: 20160216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brusegard David
CENTRAL INDEX KEY: 0001516920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 161430009
MAIL ADDRESS:
STREET 1: 4145 NORTH SERVICE ROAD, SUITE 200
CITY: BURLINGTON
STATE: A6
ZIP: L7L6A3
4
1
brusegard021616form4.xml
FORM 4
X0306
4
2016-02-16
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001516920
Brusegard David
4145 NORTH SERVICE ROAD, SUITE 200
BURLINGTON
A6
L7L6A3
ONTARIO, CANADA
0
1
0
0
Chief Operating Officer
Common Stock
2016-02-16
4
M
0
1667671
0.001
A
5615070
D
Common Stock Purchase Option
0.001
2016-02-16
4
M
0
1667671
0
D
2016-02-09
2020-10-26
Common Stock
1667671
0
D
/s/ Dr. David Brusegard, PhD
2016-02-16